Envoy Medical, Inc. (NASDAQ:COCH) Director Purchases $13,320.00 in Stock

Envoy Medical, Inc. (NASDAQ:COCH - Get Free Report) Director Mona Chetan Patel bought 4,000 shares of the business's stock in a transaction on Wednesday, September 11th. The shares were acquired at an average price of $3.33 per share, for a total transaction of $13,320.00. Following the completion of the purchase, the director now owns 5,000 shares in the company, valued at approximately $16,650. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Mona Chetan Patel also recently made the following trade(s):

• On Monday, September 9th, Mona Chetan Patel acquired 1,000 shares of Envoy Medical stock. The shares were acquired at an average cost of $3.20 per share, for a total transaction of $3,200.00.

Envoy Medical Trading Up 2.8 %

COCH stock traded up $0.09 on Wednesday, hitting $3.25. The company had a trading volume of 8,355 shares, compared to its average volume of 178,349. Envoy Medical, Inc. has a 12-month low of $0.75 and a 12-month high of $11.72. The stock's 50-day simple moving average is $2.56 and its 200 day simple moving average is $3.55.

Envoy Medical (NASDAQ:COCH - Get Free Report) last released its quarterly earnings results on Monday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by ($0.03). The firm had revenue of $0.07 million during the quarter, compared to analysts' expectations of $0.08 million. Research analysts expect that Envoy Medical, Inc. will post -1.36 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets boosted their target price on Envoy Medical from $8.50 to $8.75 and gave the stock a "buy" rating in a research report on Tuesday, September 3rd.

Institutional Investors Weigh In On Envoy Medical

A number of large investors have recently made changes to their positions in the company. Weiss Asset Management LP purchased a new position in shares of Envoy Medical during the 4th quarter worth $37,000. WealthTrust Asset Management LLC bought a new position in Envoy Medical in the 1st quarter worth $44,000. Finally, Virtu Financial LLC purchased a new position in Envoy Medical during the first quarter valued at $55,000. 8.59% of the stock is currently owned by institutional investors.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.